Valuation: Kromek Group plc

Capitalization 29.97M 36.67M 35.64M 33.49M 52.59M 3.17B 58.95M 409M 152M 1.3B 138M 135M 5.74B P/E ratio 2025 *
-9.35x
P/E ratio 2026 * -
Enterprise value 36.37M 44.5M 43.25M 40.64M 63.82M 3.85B 71.54M 496M 184M 1.58B 167M 163M 6.97B EV / Sales 2025 *
1.43x
EV / Sales 2026 * -
Free-Float
51.98%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.02%
1 week-4.12%
Current month-6.52%
1 month-15.78%
3 months-35.08%
6 months-26.97%
Current year-6.52%
More quotes
1 week
4.50
Extreme 4.5
5.00
1 month
4.50
Extreme 4.5
5.57
Current year
4.50
Extreme 4.5
5.48
1 year
4.50
Extreme 4.5
8.50
3 years
3.00
Extreme 3
18.00
5 years
3.00
Extreme 3
28.00
10 years
3.00
Extreme 3
49.93
More quotes
Director TitleAgeSince
Chief Executive Officer 52 31/03/2003
Director of Finance/CFO 63 01/11/2020
Chief Operating Officer 61 31/12/2014
Manager TitleAgeSince
Director/Board Member 52 31/03/2003
Director/Board Member 63 31/08/2013
Chairman 78 -
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.02%-4.12%-14.24%-69.10%36.67M
+1.44%+2.31%+42.58%+100.75%84.48B
+1.26%+1.46%+16.93%+52.51%36.48B
+0.58%+0.16%+3.90%+4.08%28.2B
+0.69%+1.47%+8.35%+7.42%27.02B
+1.03%+1.88%+29.63%+6.87%26.17B
+1.28%+6.92%+0.02%-3.19%26.15B
+2.80%+3.63%+21.49%-25.38%23.55B
+1.71%+2.76%+21.91%+57.23%18.17B
+2.02%+1.92%+28.60%+46.37%17.51B
Average +1.28%+1.19%+15.92%+17.76% 28.78B
Weighted average by Cap. +1.37%+1.95%+23.39%+42.01%
See all sector performances

Financials

2025 *2026 *
Net sales 25.5M 31.21M 30.33M 28.49M 44.75M 2.7B 50.16M 348M 129M 1.11B 117M 115M 4.89B -
Net income -3.4M -4.16M -4.04M -3.8M -5.97M -360M -6.69M -46.41M -17.21M -148M -15.61M -15.28M -652M -
Net Debt 6.4M 7.83M 7.61M 7.15M 11.23M 677M 12.59M 87.36M 32.4M 278M 29.39M 28.77M 1.23B -
More financial data * Estimated data
Logo Kromek Group plc
Kromek Group plc is a developer of radiation detection and bio-detection technology solutions for the advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments. Its advanced imaging segment comprises the medical, security, and industrial markets. The Company provides its original equipment manufacturer customers with detector components based on its core cadmium zinc telluride (CZT) platform to detect of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings. In CBRN detection, the Company provides nuclear radiation detection solutions to the global homeland defense and security market. Its compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of dirty bombs. The Company is also developing bio-security solutions in the CBRN detection segment.
Employees
165
More about the company
Date Price Change Volume
16/01/25 4.674 p -0.02% 133,177
15/01/25 4.675 p -0.53% 944,847
14/01/25 4.700 p 0.00% 619,265
13/01/25 4.700 p -3.59% 843,725
10/01/25 4.875 p 0.00% 197,189

Delayed Quote London S.E., January 16, 2025 at 11:16 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart KROMEK-GROUP-PLCMore Ratings

Annual profits - Rate of surprise